Sit Investment Associates Inc. Has $547,000 Holdings in Acadia Healthcare Company, Inc. $ACHC

Key Points

• Sit Investment Associates Inc. reduced their holdings in Acadia Healthcare Company by 57.6%, now owning 18,050 shares valued at approximately $547,000.
• Acadia Healthcare reported $0.83 EPS for its last quarter, exceeding analysts' expectations of $0.71, with revenue up 9.2% year-over-year to $869.23 million.
• Wall Street analysts have mixed views on Acadia Healthcare, with price targets ranging from $20.00 to $45.00 and a consensus rating of "Moderate Buy."

Sit Investment Associates Inc. reduced its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 57.6% during the 1st quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 18,050 shares of the company's stock after selling 24,500 shares during the period. Sit Investment Associates Inc.'s holdings in Acadia Healthcare were worth $547,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently modified their holdings of the company. UMB Bank n.a. raised its position in shares of Acadia Healthcare by 149.5% during the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after acquiring an additional 755 shares in the last quarter. Caitong International Asset Management Co. Ltd boosted its stake in Acadia Healthcare by 11,218.2% in the first quarter. Caitong International Asset Management Co. Ltd now owns 1,245 shares of the company's stock worth $38,000 after purchasing an additional 1,234 shares in the last quarter. State of Wyoming acquired a new position in Acadia Healthcare in the fourth quarter valued at about $56,000. Covestor Ltd increased its holdings in shares of Acadia Healthcare by 56.0% in the first quarter. Covestor Ltd now owns 2,262 shares of the company's stock worth $69,000 after acquiring an additional 812 shares in the last quarter. Finally, Aquatic Capital Management LLC acquired a new position in Acadia Healthcare during the fourth quarter valued at approximately $97,000.

Acadia Healthcare Trading Up 1.0%

Shares of ACHC stock traded up $0.2210 during trading hours on Thursday, hitting $21.5210. The company had a trading volume of 544,430 shares, compared to its average volume of 2,198,706. The company's fifty day moving average is $21.91 and its 200 day moving average is $26.57. The company has a debt-to-equity ratio of 0.73, a current ratio of 1.32 and a quick ratio of 1.32. Acadia Healthcare Company, Inc. has a fifty-two week low of $17.13 and a fifty-two week high of $82.40. The stock has a market capitalization of $1.99 billion, a PE ratio of 14.31, a price-to-earnings-growth ratio of 4.21 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings data on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, topping the consensus estimate of $0.71 by $0.12. The firm had revenue of $869.23 million for the quarter, compared to analyst estimates of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. The business's revenue for the quarter was up 9.2% compared to the same quarter last year. During the same period in the prior year, the business posted $0.91 EPS. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Research analysts expect that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on ACHC. Royal Bank Of Canada reduced their price objective on Acadia Healthcare from $43.00 to $28.00 and set an "outperform" rating on the stock in a research report on Wednesday, August 13th. KeyCorp reduced their target price on Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating on the stock in a research note on Wednesday, May 14th. Wall Street Zen upgraded shares of Acadia Healthcare from a "sell" rating to a "hold" rating in a report on Sunday, August 3rd. Stephens raised shares of Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. Finally, Cowen reiterated a "buy" rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Nine equities research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. According to data from MarketBeat, Acadia Healthcare has an average rating of "Moderate Buy" and an average price target of $40.77.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.